A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
Recruiting · NCT06862219 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma | Recruiting | Phase 4 | 2026-08-21 | NCT06862219 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 43 |
| Pfizer | 431 |
15 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Site IN91001 | Surat | India | 1 |
| Site IN91004 | Mumbai | India | 1 |
| Site IN91005 | Varanasi | India | 1 |
| Site IN91006 | Kolkata | India | 1 |
| Site IN91007 | Vellore | India | 1 |
| Site IN91008 | Mumbai | India | 1 |
| Site IN91009 | Nagpur | India | 1 |
| Site IN91010 | Bhubaneswar | India | 1 |
| Site IN91012 | Ahmedabad | India | 1 |
| Site IN91013 | Patna | India | 1 |
| Site IN91015 | Kochi | India | 1 |
| Site IN91016 | New Delhi | India | 1 |
| Site IN91017 | Dumas | India | 1 |
| Site IN91018 | Delhi | India | 1 |
| Site IN91021 | Delhi | India | 1 |